SCHEMBL363757

SCHEMBL363757

CON(C)C(=O)CC(c1ccc(Br)cc1)c1ccc(Cl)cc1C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.41
NPSR1 Q6W5P4 2/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
HTT P42858 1/20 0.41
KMT2A Q03164 3/20 0.40
UTS2R Q9UKP6 1/20 0.39
TDP1 Q9NUW8 2/20 0.37
MAPT P10636 2/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
TACR1 P25103 1/20 0.36
MEN1 O00255 2/20 0.36
KEAP1 Q14145 1/20 0.35
NFE2L2 Q16236 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
TSHR P16473 1/20 0.34
HTR2A P28223 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL366084 1.00 LMNA (0.41) LMNANPSR1CYP1A2CYP3A4CYP2D6
SCHEMBL363622 0.86 HPGD (0.40) LMNANPSR1HTTKMT2ATDP1
SCHEMBL362062 0.83 GPBAR1 (0.46) LMNANPSR1CYP1A2CYP3A4CYP2C9
SCHEMBL362134 0.83 GPBAR1 (0.46) LMNANPSR1CYP1A2CYP3A4CYP2C9
SCHEMBL362061 0.83 GPBAR1 (0.46) LMNANPSR1CYP1A2CYP3A4CYP2C9
SCHEMBL363436 0.83 KMT2A (0.47) LMNACYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL1395398 0.79 TDP1 (0.43) LMNANPSR1CYP2C19KMT2ATDP1
SCHEMBL362237 0.78 HPGD (0.41) LMNANPSR1KMT2ATDP1MAPT
SCHEMBL15949106 0.75 KMT2A (0.44) LMNANPSR1CYP1A2CYP3A4CYP2D6
SCHEMBL1390485 0.74 KMT2A (0.45) KMT2AMEN1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2593426-B1 1-HYDROXYIMINO-3-PHENYL-PROPANES HOFFMANN LA ROCHE (CH) 2014-08-20 EP disclosed
US-8765730-B2 1-hydroxyimino-3-phenyl-propanes Hoffmann-La Roche Inc (US) 2014-07-01 US disclosed
EP-2593426-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F.HOFFMANN-LA ROCHE AG (CH) 2013-05-22 EP disclosed
WO-2012007365-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-19 WO disclosed
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES GPBAR1, GPR119, ADRB1 LMNA 2651/4885NPSR1 319/4885CYP1A2 369/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.